Health-009-April-2019 Related News
MedPayRx: a new concept in blockchained digital healthcare
Marguerite Arnold introduces MedPayRx, a digital healthcare solution utilising blockchain technology to address a core challenge in health systems today.
I conceptualised MedPayRx with a...
Learn about the launching of healthcare technologies into the NHS
Professor Wendy Tindale, of the NIHR Devices for Dignity MedTech Cooperative, shares her thoughts about the world of healthcare technologies.
The National Institute for Health...
Do you know how to trace the genetic causes of congenital heart defects?
Discover more about the collaborative research from Germany that sheds new light on the genetic basis behind congenital heart defects.
Using state-of-the-art gene analysis methods,...
Cannabis-based products in a language doctors understand
Alvit LCS Pharma CEO Yona Levy tells Health Europa why cannabis-based products must be developed with the doctor in mind.
Israeli-based Alvit LCS Pharma is...
Will the European legal cannabis industry prosper?
Be Cann is on track to become an essential actor in a flourishing national legal cannabis market and burgeoning European industry.
Be Cann was created...
Medicinal cannabis in France – a work in progress
Discover how France has taken its first steps towards the legalisation of medicinal cannabis, are we seeing a shift in the French cannabis market?
In...
Bringing unique medicinal cannabis products to global markets
Discover the evolution of cannabis as Khiron Life Sciences brings its unique medicinal cannabis products to the Latin American, US and global markets.
Khiron Life...
What do you know about congenital heart defects and later-life illness?
Health Europa presents recent research into the long-term effects of congenital heart defects on both infants and their mothers.
Congenital heart defects – which include...
Australia building the evidence base on medical cannabinoids
What do you know about Australia’s first federally funded research centre regarding medical cannabinoids?
Professor Jennifer Martin introduces Health Europa to the Australia Centre for...
The SCUBY project and the world of hypertension
Discover the SCUBY project, the mission of scaling up integrated care for diabetes and hypertension in Cambodia, Slovenia and Belgium.
The University of Antwerp’s Josefien...
Learn about the missing ingredient in medicinal cannabis acceptance
MediHuanna founder and chief medical officer Dr Teresa Towpik, discusses the importance of developing the education of professionals regarding medicinal cannabis.
Towpik highlights MediHuanna’s work...
Health Europa Quarterly Issue 09
Cannabis goes under the microscope in Health Europa Quarterly issue 09, which includes a special feature on the fast-evolving medical cannabis industry in Europe,...
Canada set to take a leading role on the global stage for cannabis research
Health Europa looks at Canada’s new potential for cannabis research and education following the introduction of the Cannabis Act.
Medicinal cannabis is set to go...
Patients, progress and participation in cystic fibrosis research
Hilde De Keyser talks to Health Europa about the importance of involving patients in cystic fibrosis research.
Cystic fibrosis (CF) is an inherited and to...
Germany cautiously embraces medical cannabis regulation
A new era in medical cannabis regulation has been marked by excited anticipation and idealism in markets, caution and precision from authorities.
In the world...
Let’s talk about Little Green Pharma and medicinal cannabis
Discover Little Green Pharma – an innovator and pioneer in Australian-grown, cultivated and exported medicinal cannabis.
Managing director Fleta Solomon explains how Little Green Pharma...
Developing a first-in-class regenerative gene therapy for cystic fibrosis
OmniSpirant Limited is an Irish company developing a regenerative gene therapy with the potential to transform respiratory medicine.
The innovative OmniSpirant platform is based on...
After legalisation, what next for medical cannabis in Portugal?
Cannativa’s Maria Álvares reflects on the landmark decision of legalising medical cannabis in Portugal - Is this a game changer to the cannabis landscape?
In...
OXIMONITOR: a medical revolution in circulatory failure
Alison Sundset introduces the ODI Medical OXIMONITOR, the first non-invasive medical monitoring system providing accurate prognosis for patients with circulatory failure.
Diseases and conditions where...
Holigen: from farm to pharmacy, taking on the worldwide medical cannabis market
Holigen is the new kid in town in the worldwide medical cannabis market, here we explore their mission to become the next leader in...
